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Abstract
Innate immunity in Caenorhabditis elegans requires a conserved PMK-1 p38 mitogen-activated protein kinase (MAPK)
pathway that regulates the basal and pathogen-induced expression of immune effectors. The mechanisms by which PMK-1
p38 MAPK regulates the transcriptional activation of the C. elegans immune response have not been identified.
Furthermore, in mammalian systems the genetic analysis of physiological targets of p38 MAPK in immunity has been
limited. Here, we show that C. elegans ATF-7, a member of the conserved cyclic AMP–responsive element binding (CREB)/
activating transcription factor (ATF) family of basic-region leucine zipper (bZIP) transcription factors and an ortholog of
mammalian ATF2/ATF7, has a pivotal role in the regulation of PMK-1–mediated innate immunity. Genetic analysis of loss-of-
function alleles and a gain-of-function allele of atf-7, combined with expression analysis of PMK-1–regulated genes and
biochemical characterization of the interaction between ATF-7 and PMK-1, suggest that ATF-7 functions as a repressor of
PMK-1–regulated genes that undergoes a switch to an activator upon phosphorylation by PMK-1. Whereas loss-of-function
mutations in atf-7 can restore basal expression of PMK-1–regulated genes observed in the pmk-1 null mutant, the induction
of PMK-1–regulated genes by pathogenic Pseudomonas aeruginosa PA14 is abrogated. The switching modes of ATF-7
activity, from repressor to activator in response to activated PMK-1 p38 MAPK, are reminiscent of the mechanism of
regulation mediated by the corresponding ancestral Sko1p and Hog1p proteins in the yeast response to osmotic stress. Our
data point to the regulation of the ATF2/ATF7/CREB5 family of transcriptional regulators by p38 MAPK as an ancient
conserved mechanism for the control of innate immunity in metazoans, and suggest that ATF2/ATF7 may function in a
similar manner in the regulation of mammalian innate immunity.
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Introduction
Studies of innate immunity in phylogenetically diverse
organisms have revealed the conservation of key signaling
pathways mediating pathogen defense [1,2]. In mammals, the
initial encounter between cells of the immune system and
pathogenic bacteria triggers the activation of the innate immune
response to infection, which is under the control of the
transcription factor NF-kB and stress-activated mitogen-activated
protein kinases (MAPKs) p38 and JNK [3]. Multiple phosphor-
ylation targets for p38 and JNK MAPKs have been identified in
mammalian systems, including members of the cyclic AMP-
responsive element binding (CREB)/activating transcription
factor (ATF) family such as ATF2 [4], activating protein 1 (AP-
1), transcription factors Fos and Jun [5], and multiple kinases
including the MAPK-activated protein kinase MK2 [6]. Genetic
analysis of MK2 knockout mice is suggestive of a role for p38
MAPK regulation of MK2 in the post-transcriptional regulation
of TNF-a production [7]. However, genetic analysis of transcrip-
tion factor targets of p38 and JNK MAPKs has been limited by
lethality of knockouts and possible redundancy [8], and thus the
identification and characterization of the physiologically relevant
targets of MAPK signaling in innate immunity remains a major
challenge [9].
We have focused on the genetic dissection of innate immunity in
the nematode Caenorhabditis elegans. Previously, we identified a
requirement for a conserved NSY-1-SEK-1-PMK-1 MAPK
pathway, orthologous to mammalian ASK1 MAPKKK-MKK3/
6 MAPKK-p38 MAPK, in C. elegans innate immunity [10].
Notably, the loss of PMK-1 p38 MAPK activity in C. elegans, unlike
PLoS Genetics | www.plosgenetics.org 1 April 2010 | Volume 6 | Issue 4 | e1000892the loss of mammalian p38 MAPK, does not affect growth and
development of C. elegans on non-pathogenic bacteria. The ASK1-
MKK3/6-p38 MAPK pathway has been shown to be required for
innate immune signaling downstream of Toll-like Receptor-4
(TLR4) in mice [11], whereas NSY-1-SEK-1-PMK-1 signaling in
C. elegans is TLR-independent and functions downstream of a Toll-
Interleukin-1 Receptor (TIR) domain protein TIR-1 [12–15], an
ortholog of mammalian SARM [16–18]. The role of SARM in
mammalian innate immunity is somewhat unclear [16,17], with
some studies suggestive of a role for SARM in the inhibition of
TRIF-dependent TLR signaling [16]. Recent studies of the PMK-
1 pathway are suggestive of a role for protein kinase C-dependent
signaling upstream of TIR-1 [19,20].
The TIR-1-NSY-1-SEK-1-PMK-1 pathway acts cell autono-
mously in the intestine to regulate innate immunity in C. elegans
[21], paralleling the role of this pathway in the epidermal response
to Drechmeria [15]. The transcriptional profiling of C. elegans
mutants deficient in PMK-1 pathway activity has identified a
number of PMK-1-dependent candidate effector genes, including
C-type lectins and putative antimicrobial peptides, many of which
are induced by pathogen infection [22]. Whereas the GATA
family transcription factor ELT-2 has been implicated in the
regulation of C. elegans innate immunity in response to intestinal
infection [23], in addition to its role in the expression of all
intestinally expressed genes [24], the specific targets of PMK-1 p38
MAPK in the regulation of the immune effector response have
remained uncertain.
In this paper we report the results of a forward genetic screen
for mutants deficient in immune signaling through the PMK-1 p38
MAPK pathway. We report the identification of ATF-7, a putative
ortholog of the mammalian ATF2 family of basic-region leucine
zipper (bZIP) transcription factors, as a key downstream target of
the PMK-1 p38 MAPK pathway in C. elegans. Our data establish a
pivotal role for ATF-7 as a transcriptional regulator of the PMK-1-
mediated innate immune response in C. elegans.
Results
Isolation and characterization of mutant alleles of atf-7
We modified our prior screen for mutants with enhanced
susceptibility to pathogens (Esp phenotype) [10] to focus on the
identification of genes encoding components of PMK-1 p38
MAPK-dependent innate immunity in C. elegans. We used as our
starting strain a wild-type (WT) N2-derived strain carrying the
agIs219 transgene, which is comprised of the promoter of a PMK-
1-regulated gene, T24B8.5, encoding a ShK-like toxin peptide,
fused to green fluorescent protein (GFP) and provides an in vivo
sensor of PMK-1 pathway activity [21]. Mutagenized animals with
diminished GFP expression were enriched using the COPAS
worm sorter, and this enriched population was subsequently
transferred to Pseudomonas aeruginosa PA14 for isolation of mutants
with diminished PMK-1-dependent reporter expression and an
Esp phenotype. From an initial round of high-throughput
screening of worms derived from 140 000 mutagenized genomes,
we isolated 33 mutants representing five complementation groups
using a cutoff for Esp screening that required mutants to be dead
prior to the death of any unmutagenized worms treated in parallel
(Table 1). Using a combination of complementation testing and
sequencing of candidate genes, we determined that four of the
complementation groups correspond to genes encoding the
established TIR-1-NSY-1-SEK-1-PMK-1 pathway.
The fifth complementation group was defined by a single allele,
qd22. The qd22 mutant exhibited a marked decrease in expression
of the agIs219 transgene (Figure 1A) and conferred a strong Esp
phenotype (Figure 1B and Figure S10). The lifespan of the qd22
mutant on relatively non-pathogenic Escherichia coli OP50 was
comparable to WT (Figure S1 and Figure S16). Using lysates from
qd22 mutant worms, we carried out immunoblotting against the
activated form of PMK-1. We found that unlike the other mutants
isolated in the screen which carry mutations in PMK-1 pathway
components functioning upstream of PMK-1 [21], the qd22
mutant did not exhibit diminished levels of PMK-1 activation, and
in fact had increased levels of activated PMK-1 compared to WT
(Figure 1C). Taken together, these data suggested that the qd22
mutation affected PMK-1-dependent reporter gene expression
either at a step downstream of or parallel to PMK-1.
Using single nucleotide polymorphism (SNP)-based mapping
[25,26], we narrowed the region containing the qd22 mutation to a
250 kb region of the left arm of LG III, where we identified a
CRT missense mutation causing a P58S change in the open
reading frame defined by the gene atf-7, encoding a basic-region
leucine zipper (bZIP) domain-containing protein (Figure 2A).
Phylogenetic analysis, based on the comparison of the conserved
putative DNA binding domain sequence of ATF-7 with other
bZIP transcription factors (A.W. Reinke and A.E. Keating,
unpublished data), suggests that C. elegans ATF-7 is an ortholog
of the mammalian ATF2/ATF7/CREB5 family of bZIP tran-
scription factors [27] (Figure 2B and 2C). Injection of the fosmid
25cA04, that includes the atf-7 locus, resulted in partial rescue of
the Esp phenotype (Figure S2).
We were unable to phenocopy the diminished GFP reporter
gene expression of the atf-7(qd22) mutant by RNAi of the atf-7
gene in the WT background (Figure S3A), but interestingly, we
observed that RNAi of atf-7 in the atf-7(qd22) mutant background
resulted in reversion of the diminished GFP reporter gene
expression (Figure S3A). RNAi of atf-7 in WT worms resulted in
an Esp phenotype (Figure S3B and Figure S11), but notably,
RNAi of atf-7 in the atf-7(qd22) mutant conferred increased
pathogen resistance and partial suppression of the Esp phenotype
of the atf-7(qd22) mutant (Figure S3C and Figure S11). These data
Author Summary
We have investigated mechanisms of how the soil
nematode Caenorhabditis elegans interacts with patho-
genic bacteria. Previously, we have established that a
conserved PMK-1 p38 mitogen-activated protein kinase
(MAPK) pathway regulates immunity in C. elegans,
establishing the conservation of key innate immune
signaling pathways of mammals in the immune response
of C. elegans. Whereas multiple proteins have been
identified as potential targets of p38 MAPK in immunity,
the identification of physiological substrates of p38 MAPK
in mammalian organisms has been challenging. Here,
using a forward genetic approach to identify downstream
regulators of the C. elegans innate immune response, we
have characterized the transcription factor ATF-7, a
conserved member of the basic-region leucine zipper
(bZIP) transcription factor family orthologous to mamma-
lian ATF2. We find that ATF-7 functions as a transcriptional
regulator of PMK-1 MAPK–mediated innate immunity,
functioning as a repressor of immune gene expression
that undergoes a switch to an activator upon activation by
PMK-1. Our data point to the regulation of the ATF2/ATF7/
CREB5 family of transcriptional regulators by p38 MAPK as
an ancient conserved mechanism for the control of innate
immunity in metazoans and suggests a mechanism by
which the protean effects of p38 MAPK on the mammalian
innate immune response may be mediated.
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gene, which was further corroborated by analysis of the phenotype
of the atf-7(qd22)/atf-7(qd22 qd130) trans-heterozygote (the qd130
loss-of-function allele is described below), which is nearly as
susceptible to P. aeruginosa as the atf-7(qd22) mutant (Figure S4 and
Figure S12). Interestingly, we observed that the atf-7(qd22) allele is
recessive with respect to the Esp phenotype (Figure S4).
Based on the evidence that atf-7(qd22) was a gain-of-function,
and possibly neomorphic, mutant allele of atf-7, we anticipated
that we would be able to isolate atf-7 loss-of-function alleles from a
screen for suppressors of the attenuated GFP expression
phenotype of the atf-7(qd22) mutant. We screened 20 000 haploid
genomes for mutants with increased GFP reporter expression and
isolated an intragenic suppressor of atf-7(qd22), atf-7(qd22 qd130),
which carries a nonsense mutation resulting in an early stop codon
in the atf-7 gene (Figure 2A). The atf-7(qd22 qd130) mutant allele
suppressed the diminished GFP fluorescence phenotype of the atf-
7(qd22) mutant (Figure 1A), but only partially suppressed the Esp
phenotype, demonstrating that the atf-7 loss-of-function mutant
also has an Esp phenotype compared to WT (Figure 1B and
Figure S10).
To confirm that the observed Esp phenotype of the atf-7(qd22
qd130) mutant was caused by the nonsense mutation in atf-7,w e
also analyzed a second putative null allele of atf-7, atf-7(qd137)
(Figure 2A), which we isolated from a separate screen (described
below). The atf-7(qd137) mutant exhibited the same Esp
phenotype as that observed for the atf-7(qd22 qd130) mutant, as
well as the trans-heterozygote, atf-7(qd22 qd130)/atf-7(qd137)
(Figure 1D and Figure S13). We also carried out rescue
experiments using a transgene comprised of the genomic atf-7
locus with GFP fused to the 39 end between the atf-7 stop codon
and the 39-untranslated region (UTR). We observed that this
transgene partially rescued the Esp phenotype of the atf-7(qd22
qd130) mutant (Figure S5). The partial degree of rescue observed
for both the atf-7(qd22) and atf-7(qd22 qd130) mutants may reflect
the detrimental effects of overexpression of atf-7.
The Esp phenotype of the atf-7(qd22 qd130) mutant was
consistent with the results of the RNAi experiments (Figure S2B)
and suggests that whereas the atf-7(qd22) gain-of-function allele
confers a strong Esp phenotype, loss of atf-7 activity also
compromises pathogen resistance relative to WT. We observed
that the longevity of atf-7(qd22 qd130) and atf-7(qd137) mutants on
E. coli OP50 was comparable to that observed for WT (Figure S6
and Figure S16).
atf-7 loss-of-function alleles suppress the
immunodeficiency phenotype of pmk-1
Because atf-7(qd22) appeared to be a gain-of-function allele of
atf-7 that exhibited the same phenotypes as observed for mutants
carrying loss-of-function mutations in PMK-1 pathway compo-
nents, we hypothesized that ATF-7 might be negatively regulated
by the PMK-1 pathway and function as a repressor of the innate
immune response. To test this hypothesis, we carried out epistasis
analysis using the atf-7(qd22 qd130) and pmk-1(km25) null alleles.
We observed that the atf-7(qd22 qd130) loss-of-function allele
suppressed the diminished agIs219 GFP reporter gene expression
phenotype of the pmk-1(km25) mutant (Figure 3A). Also, the atf-
7(qd22 qd130); pmk-1(km25) double mutant had a reduced
pathogen susceptibility compared to pmk-1(km25), comparable to
that of the atf-7(qd22 qd130) single mutant (Figure 3B and Figure
S14). The partial suppression of the Esp phenotype of the pmk-
1(km25) mutant by atf-7(qd22 qd130) was rescued by a transgene
carrying wild-type atf-7 fused with GFP (Figure S7). Furthermore,
we found that atf-7(qd22 qd130) also suppressed the pathogen
susceptibility (Figure 3D and Figure S15) and diminished agIs219
GFP reporter expression (Figure 3C) phenotypes of the sek-1(km4)
mutant.
The Esp phenotypes of the atf-7(qd22 qd130); pmk-1(km25) and
atf-7(qd22 qd130); sek-1(km4) double mutants are comparable to the
Esp phenotype of atf-7(qd22 qd130) single mutant. The lack of
effect of the pmk-1(km25) or sek-1(km4) mutations on the Esp
phenotype in the atf-7(qd22 qd130) mutant background is
particularly noteworthy in view of the strong Esp phenotype
conferred by inactivation of the PMK-1 pathway in the WT
background.
Based on the genetic interaction between atf-7(qd22 qd130) and
pmk-1(km25), we anticipated that a screen aimed at isolating
suppressors of the diminished agIs219 GFP reporter expression
Table 1. List of isolates from a screen for mutants with
diminished GFP expression from the agIs219 transgene and
enhanced susceptibility to killing by P. aeruginosa PA14.
Gene Allele Mutation
nsy-1 qd1 Not identified
nsy-1 qd3 Q256*
nsy-1 qd6 W391*
nsy-1 qd8 G440E
nsy-1 qd23 W514*
nsy-1 qd25 W157*
nsy-1 qd29 Q426*
nsy-1 qd31 P867L
nsy-1 qd38 G793R
nsy-1 qd41 451 bp deletion with 2 bp insertion
nsy-1 qd44 Not identified
nsy-1 qd50 Splice site
nsy-1 qd52 Not identified
nsy-1 qd55 G673E
sek-1 qd12 R221K
sek-1 qd14 S103N
sek-1 qd24 M217I
sek-1 qd26 E220K
sek-1 qd37 G199D
sek-1 qd39 W123*
sek-1 qd60 G5R
sek-1 qd65 G212R
pmk-1 qd9 L296F
pmk-1 qd11 D161N
pmk-1 qd13 M209I
pmk-1 qd15 W353*
pmk-1 qd20 C173Y
pmk-1 qd47 W29*
pmk-1 qd49 Not identified
tir-1 qd2 A451V
tir-1 qd66 Q278*
tir-1 qd67 P460L
atf-7 qd22 P58S
Mutations in tir-1 are in reference to gene model F13B10.1b. The mutation in
atf-7 is in reference to gene model C07G2.2a.
doi:10.1371/journal.pgen.1000892.t001
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would yield additional loss-of-function alleles of atf-7. Indeed, we
isolated two more putative null alleles of atf-7, the aforementioned
atf-7(qd137) allele and atf-7(qd141) (Figure 2A), from a genetic
screen of 15 000 haploid genomes. The suppression of the
pathogen susceptibility phenotypes of PMK-1 pathway loss-of-
function mutants by atf-7 null alleles is consistent with a role for
ATF-7 downstream of activated PMK-1 in the negative regulation
of innate immunity in C. elegans.
Regulation of PMK-1–regulated genes by ATF-7
We used quantitative real-time PCR (qRT-PCR) to measure
changes in expression of three representative genes previously
identified as being regulated by the PMK-1 pathway [22]. We
observed that the atf-7(qd22) mutant, consistent with the observed
effects on agIs219 GFP reporter expression (Figure 1A), exhibited
sharply diminished expression of PMK-1-regulated genes relative
to WT on E. coli OP50, comparable to the levels observed in the
pmk-1(km25) mutant (Figure 4A). These data confirm that the
observed effects of the atf-7(qd22) mutation on agIs219 expression
reflect a change in the regulation of PMK-1-regulated genes.
The basal level of expression of PMK-1-regulated genes, as
defined by the levels of expression of genes on the relatively non-
pathogenic E. coli OP50, was comparable in the atf-7 loss-of-
function mutants and WT (Figure 4B). Confirming the observa-
tions with the agIs219 transgenic reporter, the atf-7(qd22 qd130)
loss-of-function allele suppressed the markedly diminished basal
expression of PMK-1-regulated genes in the pmk-1(km25) mutant
(Figure 4B). These data are suggestive of a role for ATF-7 in the
transcriptional repression of the basal expression of PMK-1-
regulated genes, with de-repression of these genes through
inhibition of ATF-7 by activated PMK-1. But if ATF-7 functioned
solely as a transcriptional repressor of PMK-1-regulated genes,
then an increase in basal expression of these genes might be
anticipated. However, the basal expression of PMK-1-regulated
genes is comparable to the levels observed in WT. This
observation, as well as the Esp phenotype of the atf-7 loss-of-
function mutants, is suggestive that ATF-7 functions not only as a
repressor of the PMK-1-regulated immune response, but as a
positive regulator of innate immunity as well, and thus we sought
to examine the requirement for ATF-7 in pathogen-induced gene
expression.
Figure 1. Characterization of atf-7 mutants that affect signaling downstream of PMK-1 p38 MAPK. (A) Fluorescence microscopy images
of GFP expression from the agIs219 transgene in wild-type, atf-7(qd22) and atf-7(qd22 qd130) one-day-old adults. (B) Pathogenesis assay of L4 larval
stage wild-type worms, atf-7(qd22) and atf-7(qd22 qd130) mutant animals, on P. aeruginosa PA14. All strains carry the agIs219 transgene. The
differences in susceptibility between atf-7(qd22) mutant animals and wild-type worms, atf-7(qd22) and atf-7(qd22 qd130) mutant animals, and atf-
7(qd22 qd130) mutant animals and wild-type worms are all significant (p,0.0001 for each comparison). Replicate data can be seen in Figure S10. (C)
Immunoblot analysis of worm lysates from atf-7(qd22) worms. Total PMK-1 was identified using a polyclonal antibody generated against C. elegans
PMK-1. Activated PMK-1 levels were identified using an antibody specific for the doubly phosphorylated TGY motif of activated PMK-1. (D)
Pathogenesis assay of L4 larval stage wild-type worms; atf-7(qd22 qd130) and atf-7(qd137) mutants; and atf-7(qd22 qd130)/atf-7(+), atf-7(qd137)/atf-
7(+), and atf-7(qd22 qd130)/atf-7(qd137) trans-heterozygotes, on P. aeruginosa PA14. All strains carry the agIs219 transgene. The differences in
susceptibility between atf-7(qd22 qd130) mutant animals and atf-7(qd22 qd130)/atf-7(+) trans-heterozygotes, and atf-7(qd137) mutants animals and
atf-7(qd137)/atf-7(+) trans-heterozygotes are significant (p,0.0001 for each comparison). There is no difference in susceptibility between atf-7(qd22
qd130) mutant animals and atf-7(qd22 qd130)/atf-7(qd137) trans-heterozygotes, and atf-7(qd137) mutant animals and atf-7(qd22 qd130)/atf-7(qd137)
trans-heterozygotes (p.0.35 for each comparison). Replicate data can be seen in Figure S13.
doi:10.1371/journal.pgen.1000892.g001
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up-regulated in a PMK-1-dependent manner [22]. We observe
that genes that require PMK-1 for induction by P. aeruginosa PA14
also require ATF-7 for pathogen-induced expression (Figure 4B).
Although the basal expression of PMK-1-regulated genes on E. coli
OP50 in the atf-7(qd22 qd130) and atf-7(qd137) mutants is
comparable to WT, no induction of expression is observed in
the presence of P. aeruginosa (Figure 4B). These data also suggest
dual switching roles for ATF-7, both as a PMK-1-regulated
repressor of the basal expression of PMK-1-regulated genes as well
as a PMK-1-dependent activator of PMK-1-regulated genes upon
pathogenic P. aeruginosa infection. This requirement may contrib-
ute to the observed Esp phenotype of the atf-7(qd22 qd130) mutant,
as optimal regulation of the C. elegans innate immune response may
be dependent on PMK-1 regulation of ATF-7.
Phosphorylation of ATF-7 by PMK-1
The genetic and gene expression data above are consistent with
a role for PMK-1 in the modulation of the transcriptional
regulator ATF-7. Because the PMK-1 pathway acts in the intestine
in a cell autonomous manner to regulate the innate immune
response [21], we anticipated that ATF-7 would also be expressed
in the intestine. We observed that a rescuing translational fusion of
ATF-7::GFP under the control of the endogenous promoter and 39
UTR was strongly expressed in the nuclei of intestinal cells
(Figure 5).
We next sought to obtain further evidence for a direct
interaction between activation of the PMK-1 pathway and ATF-
7. We examined whether PMK-1 could phosphorylate ATF-7 by
generating activated PMK-1 by co-expressing epitope-tagged C.
elegans atf-7, pmk-1, and sek-1 cDNAs in Cos7 cells and
immunoblotting against T7-ATF-7 to detect changes in gel
mobility indicative of phosphorylation. Expression of PMK-1 with
SEK-1, which results in activated PMK-1, produced a shift in the
T7-ATF-7 protein band indicative of a change in the phosphor-
ylation state (Figure 6A, lane 4). This shift in the ATF-7 band is
not seen when either pmk-1 or sek-1 cDNAs are not expressed
(Figure 6A, lanes 2 and 3), or when ATF-7 is immunoprecipitated
and treated with phosphatase (Figure S8). These data are
consistent with PMK-1-dependent phosphorylation of ATF-7.
We used a mutated version of PMK-1 that does not have kinase
activity to establish that ATF-7 and PMK-1 physically interact.
Immunoprecipitation using the T7 antibody, followed by immu-
noblotting using anti-HA, revealed an HA-PMK-1(kinase-dead)-
T7-ATF-7 interaction that was dependent on the activated form of
PMK-1, as determined by the requirement for co-transfection of
sek-1 cDNA (Figure 6B).
We introduced the qd22 mutation into the T7-ATF-7
expressed in Cos7 cells and found that in contrast to the WT
ATF-7, the mutant ATF-7 showed no change in gel mobility in
the presence of activated PMK-1 (Figure 6A, lane 5), suggestive
that the atf-7(qd22) allele may encode a form of the protein that
can bind PMK-1 (Figure 6B, lane 3), but cannot be phosphor-
ylated by PMK-1. The unusual nature of the atf-7(qd22) allele,
with respect to the Esp phenotype and effects on PMK-1-
regulated gene expression, coupled with the apparent insensitivity
of the corresponding mutant ATF-7 protein to PMK-1 activity,
further suggests that the phosphorylation of ATF-7 by PMK-1
may function to relieve the transcriptional repressor activity of
ATF-7.
ATF-7 confers immune response specificity to PMK-1
pathway activation
In order to determine whether our observations were specific to
infection by P. aeruginosa PA14, we examined the role of ATF-7 in
pathogen resistance to two other microbial pathogens that cause
lethal infections in C. elegans, Serratia marcescens and Enterococcus
faecalis.O nS. marcescens Db10, the pmk-1(km25) mutant had a weak
Esp phenotype (Figure 7A) compared to the strong Esp phenotype
exhibited on P. aeruginosa PA14 (Figure 3B). The atf-7(qd22 qd130)
mutant also had a similarly weak phenotype, as did the atf-7(qd22
qd130); pmk-1(km25) double mutant (Figure 7A). These data
suggest that the PMK-1 pathway and ATF-7 are required for
resistance to S. marcescens, but the comparable Esp phenotypes of
single mutants and the atf-7(qd22 qd130); pmk-1(km25) double
mutant are consistent with PMK-1 and ATF-7 functioning as
positive regulators of pathogen resistance in the same pathway, or
with ATF-7 under negative regulation by PMK-1 with ATF-7
functioning as a transcriptional repressor.
Interestingly, on the Gram-positive pathogen E. faecalis
MMH594, the atf-7(qd22 qd130) mutant does not have an
appreciable Esp phenotype (Figure 7B), suggestive that ATF-7
may not serve as a positive regulator of resistance to E. faecalis.I n
Figure 2. Mutant alleles of C. elegans atf-7, an ortholog of the
mammalian ATF2/ATF7/CREB5 family of bZIP transcription
factors. (A) Identification of mutations in the C. elegans atf-7 gene.
Changes shown in amino acid residues are in reference to the coding
region of gene model C07G2.2a. (B) Sequence alignment comparing the
DNA binding domains of C. elegans ATF-7 and human ATF-2. (C)
Phylogenetic analysis grouping C. elegans ATF-7 with the mammalian
ATF2/ATF7/CREB5 family of bZIP transcription factors.
doi:10.1371/journal.pgen.1000892.g002
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the Esp phenotype of the pmk-1(km25) mutant (Figure 7B),
suggestive that there are both ATF-7-dependent and ATF-7-
independent mechanisms downstream of PMK-1 in response to E.
faecalis. Distinct sets of genes have been observed to be induced by
exposure to different bacteria, and little is known about how the
transcriptional responses to Gram-positive bacteria and Gram-
negative bacteria differ [28]. Of note, we observed diminished
GFP expression from the agIs219 transgene on Gram-positive
bacteria relative to expression on E. coli OP50 (D.H.K.,
unpublished data). Gene expression studies of genes induced in
C. elegans infection with Gram-positive bacteria, and the identifi-
cation of such genes that are regulated by the PMK-1 pathway
may further illuminate the differences in the role of ATF-7
observed between E. faecalis and P. aeruginosa.
The PMK-1 pathway regulates the response to arsenite and
oxidative stress through regulation of the transcription factor
SKN-1 [29,30]. We observed that the atf-7(qd22 qd130) mutant
did not exhibit enhanced sensitivity to arsenite stress, and in
addition, did not suppress the arsenite sensitivity of the pmk-
1(km25) mutant or the sek-1(km4) mutant (Figure 8). In addition,
we observed that skn-1 mutants did not exhibit enhanced
susceptibility to P. aeruginosa (Figure S9). Whereas PMK-1
mediates multiple responses to environmental stressors, including
oxidative stress and pathogen infection, these data suggest that
the transcription factor substrates of PMK-1, ATF-7 and SKN-1,
confer specificity to PMK-1-mediated responses.
Discussion
We have described the identification and characterization of ATF-
7, a C. elegans ortholog of the mammalian ATF2/ATF7/CREB5
family of bZIP transcription factors, as a transcriptional regulator of
PMK-1-mediated innate immunity in C. elegans.W ei s o l a t e df o u r
mutant alleles of C. elegans atf-7 from three different forward genetic
screens. First, the gain-of-function qd22 allele was isolated from a
large-scale screen for mutants with diminished PMK-1-dependent
GFPreportergeneexpressionandanEspphenotype.Theisolationof
qd22 served as a starting point for the characterization of ATF-7, and
the analysis of this unusual gain-of-function allele provided insights
into the mechanism of ATF-7 regulation by PMK-1. The increased
levels of PMK-1 activation in the atf-7(qd22) mutant relative to WT
(Figure 1C) may reflect feedback loops that serve to counteract the
suppression of the PMK-1-mediated transcriptional response by
increasing levels of activated PMK-1. Although atf-7(qd22) acts as a
gain-of-function allele, we determined that atf-7(qd22) is recessive
with regard to pathogen susceptibility (Figure S4). We suggest that
whereas the qd22 mutant ATF-7 protein cannot be phosphorylated
by PMK-1 and thus functions as a constitutive repressor (Figure 6A),
the resulting protein may undergo changes in structure and folding
that compromise the ability of the mutant ATF-7 to compete with
WT ATF-7 at corresponding promoter sites in the atf-7(qd22)/atf-
7(+) trans-heterozygote.
Based on evidence that atf-7(qd22) was a gain-of-function allele,
we isolated the atf-7(qd22 qd130) allele as an intragenic suppressor
Figure 3. The loss-of-function atf-7(qd22 qd130) mutation suppresses the immunodeficient phenotype caused by deficient signaling in
the PMK-1 pathway. (A) Fluorescence microscopy images of GFP expression from the agIs219 transgene in pmk-1(km25) and atf-7(qd22 qd130); pmk-
1(km25)one-day-oldadults. (B) Pathogenesisassay ofL4larval stage wild-typeworms; atf-7(qd22qd130)and pmk-1(km25) mutant animals;andatf-7(qd22
qd130); pmk-1(km25) double mutant animals, on P. aeruginosa PA14. All strains carry the agIs219 transgene. The difference in susceptibility between pmk-
1(km25)mutant animals and atf-7(qd22 qd130); pmk-1(km25) doublemutantanimalsissignificant(p,0.0001).ReplicatedatacanbeseeninFigureS14.(C)
Fluorescence microscopy images of GFP expression from the agIs219 transgene in sek-1(km4) and atf-7(qd22 qd130); sek-1(km4) one-day-old adults. (D)
PathogenesisassayofL4larvalstagewild-typeworms;atf-7(qd22qd130)andsek-1(km4)mutantanimals;andatf-7(qd22qd130);sek-1(km4)double mutant
animals, on P. aeruginosa PA14. All strains except for KU25 [sek-1(km4)] carry the agIs219 transgene. The difference in susceptibility between sek-1(km4)
mutant animals and atf-7(qd22 qd130); sek-1(km4) double mutant animals is significant (p,0.0001). Replicate data can be seen in Figure S15.
doi:10.1371/journal.pgen.1000892.g003
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of pmk-1(km25) yielded two additional putative null alleles of atf-7,
qd137 and qd141. The genetic analysis of loss-of-function alleles of
atf-7 allowed us to begin to address the physiological role of ATF-7
in innate immunity. Genetic interaction analysis of atf-7 mutant
alleles suggests that PMK-1 negatively regulates ATF-7, which in
turn functions as a negative regulator of C. elegans innate immunity
to P. aeruginosa and E. faecalis. At the same time, the Esp phenotype
of atf-7 loss-of-function mutants and the analysis of P. aeruginosa-
induced gene expression were suggestive of a requirement for
ATF-7 in the activation of the inducible innate immune response,
as ATF-7 was shown to be required for the increased expression of
PMK-1-regulated genes in response to P. aeruginosa infection.
Interestingly, the lack of an Esp phenotype of atf-7(qd22 qd130) on
E. faecalis may be suggestive of the absence of a PMK-1-regulated
inducible response to E. faecalis that is regulated by ATF-7.
We showed that ATF-7 physically interacts with activated
PMK-1 and undergoes PMK-1-dependent phosphorylation in
mammalian cells in heterologous expression assays. Based on these
data, we propose that activation of the PMK-1 pathway in
response to pathogen infection results in PMK-1 phosphorylation
of ATF-7, leading to a switch in the activity of ATF-7 from
transcriptional repressor to an activator that facilitates P. aeruginosa-
induced gene expression (Figure 9). In yeast, phosphorylation of
the CREB/ATF transcription factor Sko1p downstream of the
ancestral Hog1p MAPK pathway in response to osmotic stress
converts Sko1p from a transcriptional repressor to an activator
[31]. Our data suggest that this mode of transcriptional regulation
Figure 4. ATF-7 regulation of PMK-1–regulated genes. qRT–PCR analysis of the expression of PMK-1-regulated genes. (A) L4 larval stage worms
of the indicated genotype were propagated on E. coli OP50 and RNA was prepared as described in the Methods. Expression is relative to wild-type.
Shown is the mean from two independent biological replicates with error bars representing SEM. (B) As in (A), except that worms of the indicated
geneotype were exposed to P. aeruginosa PA14 for 4 h. Expression is relative to wild-type on E. coli OP50.
doi:10.1371/journal.pgen.1000892.g004
Figure 5. ATF-7 is expressed in the nuclei of intestinal cells in C.
elegans. Fluorescence and DIC microscopy of a representative L4-
staged wild-type worm carrying an atf-7::GFP transgene under the
regulation of the endogenous genomic atf-7 promoter and 39-
untranslated region. The red fluorescence from the pharynx is due to
a Pmyo-2::RFP co-transformation marker. The rescuing capability of this
translational fusion transgene was confirmed in both the atf-7(qd22
qd130) mutant (Figure S5) and atf-7(qd22 qd130); pmk-1(km25) double
mutant (Figure S7). Scale bar, 100 mm.
doi:10.1371/journal.pgen.1000892.g005
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immunity. Further work may define the detailed mechanisms by
which ATF-7 transcriptional control is modulated by PMK-1.
In view of the multiple substrates for p38 MAPK that have been
established in mammalian cell systems and the multiple activities of
p38 MAPK in mammalian innate immunity, it is perhaps surprising
that loss of activity of a single transcription factor, the C. elegans
ortholog of mammalian ATF2, is sufficient to suppress the
immunocompromised phenotype caused by loss of p38 MAPK
activity in C. elegans. Mice homozygous for a deletion of the ATF2 gene
die shortly after birth due to the lack of pulmonary surfactant [8],
although analysis of cells from mutant mice expressing low levels of
ATF2 are suggestive of a role for ATF2 in the modulation of cytokine
expression [32]. Interestingly, these studies also indicate a role for
mammalian ATF2 in both activating and inhibitory activities on the
immune response [32]. Whether ATF2 plays a correspondingly
homologous role in mammalian innate immunity downstream of p38
MAPK, paralleling the activity of C. elegans ATF-7, awaits the further
molecular genetic analysis of the ATF2/ATF7/CREB5 family in
mammalian systems. Our data establish the SARM-p38 MAPK-
ATF-7 pathway as a major pathway of C. elegans innate immunity and
suggest that the regulation of ATF2/ATF7 family of bZIP
transcription factors by p38 MAPK may represent a key feature of
innate immunity in ancestralorganisms that was retained evenas Toll-
dependent NF-kB immune signaling was lost [33]. The mechanism of
regulation of ATF-7 activity by PMK-1 may also provide insights into
conserved mechanisms by which p38 MAPK modulates the activity of
ATF2/ATF7 in mammalian innate immunity.
Materials and Methods
C. elegans strains
C. elegans was maintained and propagated on E. coli OP50 as
described [34]. AU78, an N2-derived strain carrying the agIs219
transgene was used as the wild-type strain [21]. CB4856 was used
for single nucleotide polymorphism-based mapping [26].
Previously isolated and characterized mutants used: LG II: nsy-
1(ag3) [10], nsy-1(ky397) [35]. LG III: tir-1(qd4) [21]. LG IV: pmk-
1(km25) [36], skn-1(zu67), skn-1(zu135) [37]. LG X: sek-1(km4)
[10,38].
Mutants described in this study: ZD442 [agIs219 atf-7(qd22)
III] was isolated as described below and backcrossed three times
to its parental strain, AU78. ZD318 [agIs219 atf-7(qd22 qd130)
III] was isolated as described below and outcrossed four times to
wild-type strain N2. ZD39 [agIs219 III; pmk-1(km25) IV]w a s
made by crossing the agIs219 transgene from strain AU78 into
pmk-1(km25).Z D 3 9 5[ agIs219 III; sek-1(km4) X]w a sm a d eb y
crossing the agIs219 transgene from strain AU78 into sek-1(km4).
ZD332 [agIs219 atf-7(qd137) III; pmk-1(km25) IV] and ZD402
[agIs219 atf-7(qd141) III; pmk-1(km25) IV]w e r ei s o l a t e da s
described below. ZD332 was backcrossed three times to ZD39.
ZD350 [agIs219 atf-7(qd137) III] was made by removing pmk-
1(km25) from agIs219 atf-7(qd137); pmk-1(km25), which had been
previously backcrossed twice to ZD39, by outcrossing to N2.
ZD326 [agIs219 atf-7(qd22 qd130) III; pmk-1(km25) IV] was made
by crossing pmk-1(km25) into agIs219 atf-7(qd22 qd130) and was
outcrossed to pmk-1(km25) an additional three times. ZD340
[agIs219 atf-7(qd22 qd130) III; sek-1(km4) X] was made by crossing
sek-1(km4) into agIs219 atf-7(qd22 qd130) and was outcrossed to
sek-1(km4) an additional three times.
Pathogenesis assays
Pathogenesis assays with P. aeruginosa PA14 [39], S. marcescens
Db10 [40] and E. faecalis MMH594 [41,42] were performed as
described previously with the following modifications. Single
colonies of P. aeruginosa PA14 and S. marcescens Db10 were used to
inoculate 3 ml cultures of Luria-Bertani (LB) broth, which were
then incubated overnight at 37uC. Five microliters of the S.
marcescens Db10 culture was used to seed standard 35-mm slow-
kill assay plates, whereas five microliters of the P. aeruginosa PA14
culture was used to seed 35-mm slow-kill assay plates containing
0.05 mg/ml 5-fluorodeoxyuridine (FUDR), used to prevent eggs
Figure 6. Phosphorylation of ATF-7 by PMK-1. (A) Cos7 cells were transfected with T7-ATF-7 or T7-ATF-7 carrying the P58S qd22 mutation,
along with HA-PMK-1 and FLAG-SEK-1 as indicated. Whole cell extracts were immunoblotted with antibodies that recognize T7 (top), HA (middle),
and FLAG (bottom). (B) Cos7 cells were transfected with T7-ATF-7 or T7-ATF-7 carrying the P58S qd22 mutation, along with kinase-dead (KD) HA-PMK-
1 and FLAG-SEK-1 as indicated. ATF-7 was immunoprecipitated with anti-T7 and immunoblotted with anti-HA (top). Whole cell extract were
immunoblotted with antibodies that recognize T7 (middle top), HA (middle bottom), and FLAG (bottom).
doi:10.1371/journal.pgen.1000892.g006
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and then incubated at room temperature overnight. A single
colony of E. faecalis MMH594 was used to inoculate a 3 ml
culture of brain heart infusion (BHI) broth containing 80 mg/ml
of kanamycin, which was then incubated at 37uC for 5 hours.
Seven microliters of culture was used to seed 35-mm BHI agar
plates containing 80 mg/ml of kanamycin, which were incubated
at 25uC overnight. In all pathogenesis assays, the size of the
bacterial lawn was small, meaning that the culture was seeded in
the middle of the plate and was not spread to the edge. For each
assay, approximately 20–40 L4-staged worms were picked over to
prepared plates, with 3–5 plates per strain. The sample sizes for
each assay are provided in Table S1. All pathogenesis assays were
conducted at 25uC. Plates were checked at regular intervals for
survival and worms that did not respond to gentle prod from a
platinum wire were scored as dead. Worms on S. marcescens plates
were transferred to new plates on days 1, 2, and 3 of the assay. All
S. marcescens plates in a single assay were seeded on the same day.
Worms on P. aeruginosa PA14 plates containing FUDR and E.
faecalis MMH594 plates did not require transferring. Statistical
analyses of survival curves were performed in Prism 5 (GraphPad)
using the log-rank test function, which computes the Mantel-
Haenszel method.
Isolation of mutants with diminished agIs219 reporter
expression and enhanced susceptibility to killing by P.
aeruginosa PA14
Mutagenesis using ethyl methane sulfonate (EMS) was carried
out following standard methods [43]. The synchronized F2
generation L1 stage larvae were plated onto NGM plates seeded
Figure 9. Model for the function of ATF-7 in C. elegans innate
immunity. (A) Repression of PMK-1–regulated immune effector gene
expression by ATF-7 in the absence of PMK-1 activation. (B) Activation
of basal and pathogen-induced immune effector gene expression by
PMK-1 phosphorylation of ATF-7, which switches ATF-7 from a repressor
to an activator of transcription.
doi:10.1371/journal.pgen.1000892.g009
Figure 7. Requirement for ATF-7 in resistance to other bacterial
pathogens. (A) Pathogenesis assay of L4 larval stage wild-type worms;
atf-7(qd22 qd130) and pmk-1(km25) mutant animals; and atf-7(qd22
qd130); pmk-1(km25) double mutant animals, on S. marcescens Db10. All
strains carry the agIs219 transgene. The difference in susceptibility
between atf-7(qd22 qd130) mutant animals and wild-type worms is
significant (p,0.0001). (B) Pathogenesis assay of L4 larval stage wild-
type worms; atf-7(qd22 qd130) and pmk-1(km25) mutant animals; and
atf-7(qd22 qd130); pmk-1(km25) double mutant animals, on E. faecalis
MMH594. All strains carry the agIs219 transgene. The difference in
susceptibility between pmk-1(km25) mutant animals and atf-7(qd22
qd130); pmk-1(km25) double mutant animals is significant (p,0.0001).
There is no difference in susceptibility between atf-7(qd22 qd130)
mutant animals and wild-type worms (p.0.9).
doi:10.1371/journal.pgen.1000892.g007
Figure 8. ATF-7 does not contribute to arsenite resistance in C.
elegans. Arsenite stress assay of L4 larval stage wild-type worms; atf-
7(qd22 qd130), pmk-1(km25), and sek-1(km4) mutant animals; and atf-
7(qd22 qd130); pmk-1(km25) and atf-7(qd22 qd130); sek-1(km4) double
mutant animals. Shown is the fraction of worms alive after 18 h. Error
bars are standard deviation. The differences in survival between atf-
7(qd22 qd130) mutant animals and atf-7(qd22 qd130); pmk-1(km25)
double mutant animals, and atf-7(qd22 qd130) mutant animals and atf-
7(qd22 qd130); sek-1(km4) double mutant animals are significant
(p,0.05 for each comparison).
doi:10.1371/journal.pgen.1000892.g008
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subsequently sorted with a Union Biometrica COPAS Biosorter.
Worms with diminished fluorescence compared to wild-type
worms were directly plated onto a plate seeded with P. aeruginosa
PA14, and incubated at 25uC. The plates were screened at
24 hours for dead worms. Following the rationale of our
previously reported screen for Esp mutants [10], carcasses of
dead worms were picked to individual NGM plates seeded with E.
coli OP50, allowing the fertilized eggs inside each carcass to hatch
so that the mutant strains could be recovered. In three separate
screens a total of 140 000 haploid genomes were mutagenized. We
note that the yield of the screen is strongly dependent on the time
at which the Esp screening takes place, and that the 24 h time
point represented a particularly stringent time such that siblings
were rarely isolated among the mutant isolates. The early time of
screening also accounts for the relatively low yield of mutants from
the number of genomes mutagenized and the high specificity of
isolated mutations for the PMK-1 pathway.
Single-nucleotide polymorphism (SNP)-based mapping using
the C. elegans isolate CB4856 was performed as reported [26] with
modifications utilizing SNPs that were analyzed by the DraI
restriction enzyme for the rapid rough mapping of mutant isolates
[25]. Once chromosomal linkage was determined, complementa-
tion testing was performed using previously isolated mutant alleles
(tir-1(qd4), nsy-1(ag3) and nsy-1(ky397), sek-1(km4), and pmk-
1(km25)). After assignment of the isolated alleles into complemen-
tation groups, the open reading frame of the affected gene was
sequenced to identify the causative mutation in each allele. Isolates
from the screen and the identified mutations are shown in Table 1.
Using this approach, a single mutant allele not corresponding to
previously identified mutants, qd22, was isolated. Fine mapping of
qd22 was carried out using CB4856 SNP-based mapping. The
location of qd22 on the left arm of LG III was in the vicinity of the
agIs219 integrated transgenic array, and thus a strain carrying qd22
without agIs219 was generated and SNP mapping was carried out
using the Esp phenotype of qd22. In order to facilitate
interpretation of the pathogen killing assays with recombinants,
a strain carrying the qd22 mutation (without the agIs219 transgene)
and the CB4856-derived allele of npr-1, 215F, was utilized for
crossing with CB4856 because of the enhanced susceptibility
conferred by the 215F allele of npr-1 relative to the Bristol N2
background [44,45] in which qd22 was initially isolated.
Isolation of atf-7(qd22 qd130)
A forward genetic screen to identify suppressors of the atf-
7(qd22) diminished agIs219 GFP fluorescence phenotype was
carried out similarly as above. Briefly, C. elegans atf-7(qd22)
hermaphrodites carrying agIs219 were mutagenized with EMS
and synchronized larvae of the F2 generation were plated onto
NGM plates seeded with E. coli OP50 and incubated for 55 hours
at 20uC. The F2 worms were screened for GFP expression from
the agIs219 transgene using a Zeiss Stereo V12 Discovery
microscope with a GFP wide-band fluorescence cube. Any F2
worm with increased fluorescence compared to atf-7(qd22) was
singled to a NGM plate seeded with E. coli OP50. Isolates with
increased fluorescence were then tested for suppression of the atf-
7(qd22) Esp phenotype to P. aeruginosa PA14 using the PA14
pathogenesis assay described above. The atf-7 coding region was
then sequenced in isolates that had both increased fluorescence
and diminished pathogen susceptibility.
Isolation of atf-7(qd137) and atf-7(qd141)
A genetic screen for suppressors of the pmk-1(km25) mutant was
carried out using ZD39 as the starting strain and following a
procedure as outlined for the isolation of atf-7(qd22) suppressor
mutants.
Generation of transgenic animals
C. elegans genomic fosmids (Geneservice) were isolated using
Qiagen Miniprep Kits following the standard protocol. Fosmid
24cA04 was injected into ZD442 at a concentration of 20 ng/ml,
along with 25 ng/mlo fPmyo-2::RFP as a co-injection marker and
55 ng/ml of pBlueScript (Stratagene) as carrier DNA. The
fluorescently-tagged atf-7 construct was generated by yeast-
mediated ligation of genomic fragments generated by PCR using
fosmid 25cA04 as template DNA and Phusion high-fidelity DNA
polymerase (New England Biolabs). A 22794 bp genomic region,
from 7474 to 30267 with respect to fosmid 25cA04, was covered in
the fluorescently-tagged atf-7 construct. This construct was
injected into ZD326 at a concentration of 20 ng/ml, along with
32 ng/mlo fPmyo-2::RFP as a co-injection marker and 10 ng/mlo f
pBlueScript (Stratagene) as carrier DNA. Two independent lines
carrying this construct were crossed into strain ZD318 using
standard genetic techniques.
Yeast-mediated ligation construction of atf-7::GFP
Yeast-mediated ligation of atf-7::GFP was performed as
previously described [46]. Briefly, the 22794 bp operonic region
containing the atf-7 gene was amplified in fragments ranging in
size from ,1 kb to 4 kb in 8 separate PCR reactions with at least a
50 bp overlap between adjacent fragments. The gene encoding
GFP was amplified from the Fire vector pPD95.75 [47]. The 9
PCR products, along with destination vector pRS426 (ATCC)
digested with BamH1 and Xho1 restriction enzymes (New
England Biolabs), were transformed into yeast strain FY2
following standard procedures. Phenol-chloroform extraction was
used to isolate yeast DNA, which was then transformed into DH5-
a electrocompetent cells (Invitrogen) and isolated using Qiagen
Miniprep Kits following the standard protocol.
Quantitative real-time PCR
Synchronized populations of wild-type and indicated mutant
strains were grown to the L4 larval stage. For P. aeruginosa exposure
experiments, L4 stage worms were washed onto plates seeded with
E. coli OP50 or P. aeruginosa PA14 in parallel, dried, and incubated
for four hours at 25uC. Samples were collected, frozen in liquid
nitrogen, and stored at 280uC before RNA extraction using TRI
reagent (Ambion). cDNA was prepared with the Retroscript kit
(Ambion) using oligo dT primers. The reverse transcription
reaction was also performed without reverse transcriptase for
each sample, and subsequent qRT-PCR on these control reactions
showed that no contaminating genomic DNA was present. qRT-
PCR was performed with a Mastercycler Realplex (Eppendorf)
with SYBR Green detection in triplicate reactions of 20 ml. All
primers were previously reported, and relative expression between
samples was determined using snb-1 as a reference gene [22]. Fold
change was calculated using the Pfaffl method [48]. Standardiza-
tion between two biological replicates was performed as described
[49].
RNAi of atf-7
A 771 bp segment of the atf-7 coding region, corresponding to
bases 11532 to 12303 with respect to cosmid C07G2, was
amplified by PCR and subcloned into the Fire vector L4440.
RNAi by bacterial feeding using E. coli HT115 bacteria expressing
either the L4440-derived atf-7 RNAi vector or the empty L4440
vector (control RNAi) was carried out as reported [50]. L4 animals
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were assayed for susceptibility to P. aeruginosa PA14 or analyzed for
GFP expression from the agIs219 transgene.
Immunoblotting of C. elegans lysates
Immunoblotting against C. elegans PMK-1 and activated PMK-1
(Promega) was carried out as described previously [10].
Visualization of agIs219 GFP reporter gene expression
and fluorescently-tagged atf-7
To visualize expression of the agIs219 reporter, L4-staged
worms, grown at 20uC, were picked over to normal maintenance
plates and placed at 20uC overnight. After approximately 18 h,
worms were mounted on 2% agarose pads and immobilized in
10 mM sodium azide. Slides were viewed using an AxioImager Z1
fluorescence microscope (Zeiss) with an A-Plan 10X/0.25
objective (Zeiss) and pictures were taken using an AxioCam
HRm camera. To visualize expression of fluorescently-tagged atf-
7, L4-staged worms, grown on NGM agar plates seeded with E.
coli OP50 at 20uC, were mounted and imaged as described above
with a Plan-Apochromat 20X/0.8 objective (Zeiss). Background
intestinal autofluorescence was removed by taking a picture with
the DAPI filter and subtracting the resulting picture from the
image taken with the GFP filter.
Expression in Cos7 cells, immunoprecipitation, and
immunoblotting
Cos7 cells were maintained in DMEM supplemented with 10%
fetal calf serum, 100 mg/ml penicillin G and 100 mg/ml
streptomycin at 37uC and 5% CO2. Cos7 cells (1610
6) were
plated in 6-cm dishes and transfected with a total of 6 mg DNA
containing various expression vectors by using FuGENE6 (Roshe).
The ATF-7 expression vector contained the atf-7c isoform. After
48 h, cells were collected and washed once with ice-cold
phosphate-buffered saline (PBS) and lysed in 0.6 ml of extraction
buffer (20 mM HEPES, pH 7.4, 150 mM NaCl, 1.5 mM MgCl2,
2 mM EGTA, 2 mM dithiothreitol, 1 mM phenylmethylsulfonyl
fluoride, 1.7 mg/ml aprotinin and 0.5% Triton X-100). Cellular
debris was removed by centrifugation at 10 0006g for 5 min.
Small aliquots of each cell lysate were boiled with SDS-sample
buffer and were used as whole cell extracts. Remaining cell lysates
were divided into 200 ml and each cell lysate was incubated with
0.5 mg of various antibodies and 10 ml protein G-Sepharose
(Amersham Biosciences, Piscataway, NJ). The immune complexes
were washed five times with wash buffer (20 mM HEPES, pH 7.4,
150 mM NaCl) and then boiled with SDS-sample buffer.
Phosphatase treatment was performed on immunoprecipitated
samples with Lambda protein phosphatase (New England Biolabs)
at 30uC for 10 minutes. Immunoblotting was performed as
described previously [51].
Arsenite stress assays
Sensitivity of mutant strains to oxidative stress was determined
using sodium arsenite. Briefly, mutant worms were grown on E.
coli OP50. L4-staged animals were transferred to standard slow-
killing plates supplemented with 5 mM sodium arsenite and
0.05 mg/ml of FUDR, seeded with concentrated E. coli OP50.
The sample sizes for the arsenite stress assay are provided in
Table S1. Stress assays were performed at 20uC. Animals were
considered dead when they no longer responded to a gentle prod
with a platinum wire. Statistical analysis of data was performed in
Prism 5 (GraphPad) using an unpaired, two-tailed, Student’s
t-test.
Lifespan assays
Strains used in the lifespan assays were maintained on E. coli
OP50 at 20uC. Approximately 40 L4-staged worms (Day 0) were
picked over to NGM plates containing 0.05 mg/ml of FUDR,
seeded with E. coli OP50. Four to five plates for each strain were
used in each experiment and plates that had become contaminat-
ed or plates in which the worms had borrowed were excluded
upon the appearance of contamination/borrowing. Worms that
had protruding/exploding vulvas and worms that crawled off the
plate were censored. The sample sizes for each assay are provided
in Table S1. Lifespan assays were performed at 20uC. Animals
were considered dead when they no longer responded to a gentle
prod with a platinum wire.
Supporting Information
Figure S1 Lifespan of atf-7(qd22) and WT worms on E. coli
OP50. Lifespan assay of L4 larval stage wild-type worms and atf-
7(qd22) mutant animals on E. coli OP50. Both strains carry the
agIs219 transgene. Replicate data can be seen in Figure S16.
Found at: doi:10.1371/journal.pgen.1000892.s001 (0.13 MB PDF)
Figure S2 Rescue of atf-7(qd22) Esp phenotype. Pathogenesis
assay of L4 larval stage wild-type worms, atf-7(qd22) mutant
animals, and three independent transgenic lines (qdEx14, qdEx15,
and qdEx16)o fatf-7(qd22) mutant animals carrying fosmid
25cA04. All strains carry the agIs219 transgene. The difference
in susceptibility between atf-7(qd22) mutant animals and each
transgenic line carrying fosmid 25cA04 is significant (p,0.0001).
Found at: doi:10.1371/journal.pgen.1000892.s002 (0.13 MB PDF)
Figure S3 atf-7(qd22) is a gain-of-function allele. (A) Fluores-
cence microscopy images of GFP expression from the agIs219
transgene in wild-type worms and atf-7(qd22) mutant worms each
exposed to both control RNAi and RNAi of atf-7. (B) Pathogenesis
assay comparing the effects of control RNAi and RNAi of atf-7 on
survival of wild-type worms on P. aeruginosa PA14. The difference
in susceptibility between wild-type worms treated with control
RNAi and atf-7 RNAi is significant (p,0.0001). Replicate data can
be seen in Figure S11. (C) Pathogenesis assay comparing the effects
of control RNAi and RNAi of atf-7 on survival of atf-7(qd22)
mutant animals on P. aeruginosa PA14. The difference in
susceptibility between atf-7(qd22) mutant animals treated with
control RNAi and atf-7 RNAi is significant (p,0.0001). Replicate
data can be seen in Figure S11.
Found at: doi:10.1371/journal.pgen.1000892.s003 (0.30 MB PDF)
Figure S4 atf-7(qd22) confers a recessive Esp phenotype.
Pathogenesis assay of L4 larval stage wild-type worms; atf-
7(qd22) and atf-7(qd22 qd130) mutant animals; and atf-7(qd22)/
atf-7(+) and atf-7(qd22)/atf-7(qd22 qd130) trans-heterozygotes, on
P. aeruginosa PA14. All strains carry the agIs219 transgene. The
differences in susceptibility between atf-7(qd22) mutant animals
and atf-7(qd22)/atf-7(+) trans-heterozygotes, and atf-7(qd22 qd130)
mutant animals and atf-7(qd22)/atf-7(qd22 qd130) trans-heterozy-
gotes are significant (p,0.0001 for each comparison). Replicate
data can be seen in Figure S12.
Found at: doi:10.1371/journal.pgen.1000892.s004 (0.13 MB PDF)
Figure S5 Expression of atf-7::GFP rescues the atf-7(qd22 qd130)
Esp phenotype. Pathogenesis assay of wild-type worms, atf-7(qd22
qd130) mutant animals, and two independent transgenic lines
(qdEx17 and qdEx19)o fatf-7(qd22 qd130) mutant animals carrying
the atf-7::GFP construct under the control of the endogenous atf-7
genomic promoter and 39- untranslated region, on P. aeruginosa
PA14. All strains carry the agIs219 transgene. The difference in
ATF-7 in C. elegans Innate Immunity
PLoS Genetics | www.plosgenetics.org 11 April 2010 | Volume 6 | Issue 4 | e1000892susceptibility between atf-7(qd22 qd130) mutant animals and each
transgenic line carrying the atf-7::GFP transgene is significant
(p,0.0001 for each comparison).
Found at: doi:10.1371/journal.pgen.1000892.s005 (0.13 MB PDF)
Figure S6 Lifespan of atf-7 loss-of-function mutants and WT
worms on E. coli OP50. Lifespan assay of L4 larval stage wild-type
worms, atf-7(qd22 qd130) and atf-7(qd137) mutant animals on E.
coli OP50. All strains carry the agIs219 transgene. Replicate data
can be seen in Figure S16.
Found at: doi:10.1371/journal.pgen.1000892.s006 (0.13 MB PDF)
Figure S7 Expression of atf-7::GFP rescues the atf-7(qd22 qd130)
suppression of pmk-1(km25). Pathogenesis assay of pmk-1(km25)
mutant animals and atf-7(qd22 qd130); pmk-1(km25) double mutant
animals, along with three independent transgenic lines (qdEx17,
qdEx18, and qdEx19)o fatf-7(qd22 qd130); pmk-1(km25) double
mutant animals carrying the atf-7::GFP construct under the control
of the endogenous atf-7 genomic promoter and 39-untranslated
region, on P. aeruginosa PA14. All strains carry the agIs219
transgene. The difference in susceptibility between atf-7(qd22
qd130); pmk-1(km25) double mutant animals and each transgenic
line carrying the atf-7::GFP transgene is significant (p,0.0001 for
each comparison).
Found at: doi:10.1371/journal.pgen.1000892.s007 (0.13 MB PDF)
Figure S8 PMK-1 phosphorylation of ATF-7 is sensitive to
phosphatase. Cos7 cells were transfected with T7-ATF-7, HA-
PMK-1, and FLAG-SEK-1 as indicated. ATF-7 was immunopre-
cipitated with anti-T7, treated with phosphatase where indicated,
and immunoblotted with anti-T7 (top). Whole cell extracts were
immunoblotted with antibodies that recognize HA (middle) and
FLAG (bottom).
Found at: doi:10.1371/journal.pgen.1000892.s008 (0.20 MB PDF)
Figure S9 skn-1 mutants do not exhibit an Esp phenotype.
Pathogenesis assay of L4 larval stage wild-type worms, skn-1(zu67)
and skn-1(zu135) mutant animals on P. aeruginosa PA14.
Found at: doi:10.1371/journal.pgen.1000892.s009 (0.13 MB PDF)
Figure S10 Replicate of pathogenesis assay shown in Figure 1B.
Chart and bar graphs showing the LT50 means, LT50 standard
deviations (S.D.), and sample sizes from two independent P.
aeruginosa pathogenesis assays with wild-type worms, atf-7(qd22)
and atf-7(qd22 qd130) mutant animals.
Found at: doi:10.1371/journal.pgen.1000892.s010 (0.18 MB PDF)
Figure S11 Replicate of pathogenesis assay shown in Figure S3B
and S3C. Chart and bar graphs showing the LT50 means, LT50
standard deviations (S.D.), and sample sizes from two independent
P. aeruginosa pathogenesis assays with wild-type worms treated with
control RNAi and atf-7 RNAi, and atf-7(qd22) mutant animals
treated with control RNAi and atf-7 RNAi.
Found at: doi:10.1371/journal.pgen.1000892.s011 (0.19 MB PDF)
Figure S12 Replicate of pathogenesis assay shown in Figure S4.
Chart and bar graphs showing the LT50 means, LT50 standard
deviations (S.D.), and sample sizes from two independent P.
aeruginosa pathogenesis assays with wild-type worms; atf-7(qd22)
and atf-7(qd22 q130) mutant animals; and atf-7(qd22)/atf-7(+),
atf-7(qd22 qd130)/atf-7(+), and atf-7(qd22)/atf-7(qd22 qd130)
trans-heterozygotes.
Found at: doi:10.1371/journal.pgen.1000892.s012 (0.20 MB PDF)
Figure S13 Replicate of pathogenesis assay shown in Figure 1D.
Chart and bar graphs showing the LT50 means, LT50 standard
deviations (S.D.), and sample sizes from two independent P.
aeruginosa pathogenesis assays with wild-type worms; atf-7(qd22
q130) and atf-7(qd137) mutant animals; and atf-7(qd22 qd130)/atf-
7(+), atf-7(qd137)/atf-7(+), and atf-7(qd22 qd130)/atf-7(qd137)
trans-heterozygotes.
Found at: doi:10.1371/journal.pgen.1000892.s013 (0.20 MB PDF)
Figure S14 Replicate of pathogenesis assay shown in Figure 3B.
Chart and bar graphs showing the LT50 means, LT50 standard
deviations (S.D.), and sample sizes from two independent P.
aeruginosa pathogenesis assays with wild-type worms; atf-7(qd22
q130) and pmk-1(km25) mutant animals; and atf-7(qd22 qd130);
pmk-1(km25) double mutant animals.
Found at: doi:10.1371/journal.pgen.1000892.s014 (0.19 MB PDF)
Figure S15 Replicate of pathogenesis assay shown in Figure 3D.
Chart and bar graphs showing the LT50 means, LT50 standard
deviations (S.D.), and sample sizes from two independent P.
aeruginosa pathogenesis assays with wild-type worms; atf-7(qd22
q130) and sek-1(km4) mutant animals; and atf-7(qd22 qd130); sek-
1(km4) double mutant animals.
Found at: doi:10.1371/journal.pgen.1000892.s015 (0.19 MB PDF)
Figure S16 Replicate of lifespan assay shown in Figure S1 and
Figure S6. Chart and bar graphs showing the LT50 means, LT50
standard deviations (S.D.), and sample sizes from two independent
lifespan assays with wild-type worms, atf-7(qd22), atf-7(qd22 q130),
and atf-7(qd137) mutant animals.
Found at: doi:10.1371/journal.pgen.1000892.s016 (0.18 MB PDF)
Table S1 Sample sizes for each pathogenesis, arsenite stress, and
lifespan assay. Chart showing the sample sizes for each
pathogenesis, arsenite stress, and lifespan assay presented in this
work. Sample size does not include censored worms.
Found at: doi:10.1371/journal.pgen.1000892.s017 (0.16 MB PDF)
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